首页 | 官方网站   微博 | 高级检索  
     


Efficacy and safety of edoxaban for treatment of venous thromboembolism: a subanalysis of East Asian patients in the Hokusai‐VTE trial
Authors:M Nakamura  Y Q Wang  C Wang  D Oh  W‐H Yin  T Kimura  K Miyazaki  K Abe  M Mercuri  L H Lee  A Segers  H Büller
Affiliation:1. Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu, Mie, Japan;2. Zhongshan Hospital, Fudan University, Shanghai, China;3. National Clinical Research Center of Respiratory Diseases, Capital Medical University, Beijing, China;4. Department of Respiratory Medicine, Capital Medical University, Beijing, China;5. China‐Japan Friendship Hospital, Beijing, China;6. CHA Bundang Medical Center, CHA University, Gyeongghi‐do, South Korea;7. Heart Center, Cheng Hsin General Hospital, Taipei, Taiwan;8. Faculty of Medicine, National Yang Ming University, Taipei, Taiwan;9. Clinical Planning Department, Daiichi Sankyo Co. Ltd, Tokyo, Japan;10. Asia Development Department, Daiichi Sankyo Co. Ltd, Tokyo, Japan;11. Clinical Data & Biostatistics Department, Daiichi Sankyo Co. Ltd, Tokyo, Japan;12. Clinical Development Department, Daiichi Sankyo Pharma Development, Edison, NJ, USA;13. Department of Hematology, Singapore General Hospital, Singapore, Singapore;14. ITREAS, Amsterdam, the Netherlands;15. Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
Abstract:
Keywords:edoxaban  safety  treatment efficacy  venous thromboembolism  warfarin
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号